Bottom line: We dont know yet how, or if, GLP-1 drugs cause NAION or other eye problems
Active screening for GLP-1-RA use, consideration of extended discontinuation intervals, and routine bedside gastric ultrasound should be incorporated into perioperative protocols to enhance patient safety
The improvements in symptoms are relatively modest. The trial of semaglutide assessed exercise function using a metric known as the six-minute walk test
Significant weight loss (10% or more of body weight) typically occurs by months 4 to 6 at maintenance doses
Medications can stay in your body for a variable amount of time, and the plasma you donate may be used in critical treatments for patients with specific health conditions
However, the FDA labels for all semaglutide products note that serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported in patients treated with semaglutide